Stress oxydatif And NotZHIGAO HUANG
List of bibliographic references
Number of relevant bibliographic references: 32.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000000 | Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada] | Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis |
| 000028 | D. Ouazia [Canada] ; L.-C. Jr Levros [Canada] ; E. Rassart [Canada] ; R. R. Desrosiers [Canada] | DOPAMINE DOWN-REGULATION OF PROTEIN L-ISOASPARTYL METHYLTRANSFERASE IS DEPENDENT ON REACTIVE OXYGEN SPECIES IN SH-SY5Y CELLS |
| 000127 | Alvin P. Joselin [Canada] ; Sarah J. Hewitt [Canada] ; Steve M. Callaghan [Canada] ; Raymond H. Kim [Canada] ; Young-Hwa Chung [Corée du Sud] ; Tak W. Mak [Canada] ; JIE SHEN [États-Unis] ; Ruth S. Slack [Canada] ; David S. Park [Canada, Corée du Sud] | ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons |
| 000252 | Shivraj S. Jhala [Canada] ; Alan S. Hazell [Canada] | Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism |
| 000450 | Katrina Mcgonigal [Canada] ; Jamshid Tanha [Canada] ; Elitza Palazov [Canada] ; SHENGHUA LI [Canada] ; Deyzi Gueorguieva-Owens [Canada] ; Siyaram Pandey [Canada] | Isolation and Functional Characterization of Single Domain Antibody Modulators of Caspase-3 and Apoptosis |
| 000464 | Hyman M. Schipper [Canada] ; WEI SONG [Canada] ; Hillel Zukor [Canada] ; Jacob R. Hascalovici [Canada] ; David Zeligman [Canada] | Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement |
| 000465 | Hillel Zukor [Canada] ; WEI SONG [Canada] ; Adrienne Liberman [Canada] ; JEANNIE MUI [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | HO-1-mediated macroautophagy : a mechanism for unregulated iron deposition in aging and degenerating neural tissues |
| 000545 | Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial Reactions in Parkinson's Disease |
| 000590 | Matthew J. Lavoie [États-Unis] ; Giuseppe P. Cortese [États-Unis] ; Beth L. Ostaszewski [États-Unis] ; Michael G. Schlossmacher [Canada] | The effects of oxidative stress on parkin and other E3 ligases |
| 000630 | K. V. Rama Rao [États-Unis] ; P. V. B. Reddy [États-Unis] ; A. S. Hazell [Canada] ; M. D. Norenberg [États-Unis] | Manganese induces cell swelling in cultured astrocytes |
| 000754 | Alan S. Hazell [Canada] ; Louise Normandin [Canada] ; Michael D. Norenberg [États-Unis] ; Gregory Kennedy [Canada] ; Jae-Hyuk Yi [Canada] | Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment |
| 000756 | Fernanda G. De Souza [Brésil] ; Mayra D. B. Rodrigues [Brésil] ; Sergio Tufik [Brésil] ; José N. Nobrega [Canada] ; Vania D'Almeida [Brésil] | Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats |
| 000860 | S. Mccarthy [Canada] ; M. Somayajulu [Canada] ; M. Sikorska [Canada] ; H. Borowy-Borowski [Canada] ; S. Pandey [Canada] | Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10 |
| 000935 | Paul S. Fitzmaurice [Canada] ; LEE ANG [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
| 000995 | Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
| 000A34 | Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity |
| 000A57 | Andrzej Friedman [Pologne] ; Jolanta Galazka-Friedman [Pologne] | The current state of free radicals in Parkinson's disease: Nigral iron as a trigger of oxidative stress |
| 000B11 | B. M. Ross [Canada] ; N. Mamalias [Canada] ; A. Moszczynska [Canada] ; A. H. Rajput [Canada] ; S. J. Kish [Canada] | Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease |
| 000B15 | Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël] | Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression |
| 000B49 | Hong Y. Choi [Canada] ; Jin H. Song [Canada] ; Dong K. Park [Corée du Sud] ; Gregory M. Ross [Canada] | The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics |
| 000C46 | H. M. Schipper [Canada] ; L. Bernier [Canada] ; K. Mehindate [Canada] ; D. Frankel [Canada] | Mitochondrial iron sequestration in dopamine-challenged astroglia : Role of heme oxygenase-1 and the permeability transition pore |
| 000C66 | D. Frankel [Canada] ; H. M. Schipper [Canada] | Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury |
| 000C98 | H. M. Schipper [Canada] ; A. Liberman [Canada] ; E. G. Stopa [États-Unis] | Neural heme oxygenase-1 expression in idiopathic Parkinson's disease |
| 000D01 | B. M. Ross [Canada] ; A. Moszczynska [Canada] ; J. Erlich [Canada] ; S. J. Kish [Canada] | Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra : Possible implications for Parkinson's disease |
| 000D11 | FENGQINSI [Canada] ; G. M. Ross [Canada] ; S. H. Shin [Canada] | Glutathione protects PC12 cells from ascorbate- and dopamine-induced apoptosis |
| 000D60 | C.-T. Lai [Canada] ; P. H. Yu [Canada] | R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells |
| 000D71 | J. S. Bains [Canada] ; C. A. Shaw [Canada] | Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death |
| 000D91 | C.-T. Lai [Canada] ; P. H. Yu [Canada] | Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells : effects of oxidative stress and antioxidative factors |
| 000E35 | C. Bergeron [Canada] ; C. Petrunka ; L. Weyer | Copper/zinc superoxide dismutase expression in the human central nervous system : correlation with selective neuronal vulnerability |
| 000E67 | C. Thiffault [Canada] ; N. Aumont ; R. Quirion [Canada] ; J. Poirier | Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain |
| 000E73 | G. M. Ross [Canada] ; B. E. Mccarry ; R. K. Mishra [Canada] | Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene |
| 000F74 | J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; K. Prasad | Serum antioxidant enzyme activity in Parkinson's disease |
| This area was generated with Dilib version V0.6.29. |  |